OTC Markets OTCQX - Delayed Quote USD

Integrated BioPharma, Inc. (INBP)

Compare
0.2898
0.0000
(0.00%)
At close: 1:46:09 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Riva Kay Sheppard Co-CEO & Director 283.49k 9.5k 1967
Ms. Christina Kay Co-CEO & Director 283.49k 9.5k 1970
Ms. Dina L. Masi Senior VP, CFO & Secretary 297.02k 9.5k 1961
Mr. Jamie E. Levey Head of Investor Relations -- -- --

Integrated BioPharma, Inc.

Building 15
225 Long Avenue
Hillside, NJ 07205
United States
973 926 0816 https://ir.ibiopharma.com
Industry: 
Packaged Foods
Full Time Employees: 
147

Description

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through two segments, Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brand names, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Corporate Governance

Integrated BioPharma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 8:00 PM UTC - May 12, 2025 at 8:00 PM UTC

Integrated BioPharma, Inc. Earnings Date

Recent Events

February 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 28, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

September 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 20, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

May 10, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 12, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 27, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters